Skip to content
★ Sign in to follow
AC

Ayer Capital Management, LP

Shareholder
Related company / holding
Cascadian Therapeutics, Inc.Abeona Therapeutics Inc.Iovance Biotherapeutics, Inc.
Total declarations
14
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€24.2M

Latest filing published 08 May 2015 for Iovance Biotherapeutics, INC., €23.9M.

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

No signal scores available.

Ayer Capital Management, LP: trading record in brief

This profile gathers the share dealings of Ayer Capital Management, LP across 3 companies, led by Cascadian Therapeutics, Inc., Abeona Therapeutics Inc. and Iovance Biotherapeutics, Inc. Over a trading history stretching from 6 May 2011 to 1 May 2015, the count stands at 14 filings.

The open-market record consists of 6 sales worth €24.2M, with no purchase. Outside the open market, there are 6 share grants. In 2015 alone, the filings show no purchases and 1 sale.

The record was last updated on 8 May 2015 with an open-market sale (€23.9M) in Iovance Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Ayer Capital Management, LP

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total

14 of 14 declarations